TransMedics Group Inc (TMDX)
Operating return on assets (Operating ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 37,496 | -28,727 | -31,437 | -39,428 | -26,384 |
| Total assets | US$ in thousands | 804,076 | 706,047 | 277,147 | 134,893 | 152,026 |
| Operating ROA | 4.66% | -4.07% | -11.34% | -29.23% | -17.35% |
December 31, 2024 calculation
Operating ROA = Operating income ÷ Total assets
= $37,496K ÷ $804,076K
= 4.66%
The operating return on assets (ROA) for TransMedics Group Inc has exhibited significant fluctuations over the past five years. The company experienced negative operating ROA figures in 2020 and 2021, indicating that its operating income generated from its assets was insufficient to cover the asset base during those periods.
In 2022, there was a moderate improvement in the operating ROA, although it remained negative at -11.34%. This suggests that the company was able to enhance its operational efficiency and generate slightly higher operating income relative to its asset base compared to the previous years.
By the end of 2023, TransMedics Group Inc further improved its operating ROA to -4.07%, indicating a continuing trend towards better asset utilization and operational performance. Finally, in 2024, the company achieved a positive operating ROA of 4.66%, signifying that the operating income generated from its assets exceeded the asset base, reflecting a potentially favorable turnaround in operational efficiency and profitability.
Overall, the fluctuating trend in TransMedics Group Inc's operating ROA demonstrates the company's efforts to enhance its operational performance and asset utilization over the five-year period, with the most recent year showing a positive outcome.
Peer comparison
Dec 31, 2024